Schedule 13G ownership disclosure

AVADEL PHARMACEUTICALS PLC

Security class unavailable · CUSIP: 05337M104

Event date: 2021-11-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
42,000
Percent of class
0.0700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-21-003200
Form type
SC 13G
Filer
AVADEL PHARMACEUTICALS PLC
CIK
CIK 1012477
Filed
Nov 12, 2021
Reporting period
Nov 09, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub